Find Academic Supervisors

Vincent Quagliarello, MD, is Professor of Medicine in the Department of Infectious Diseases at Yale School of Medicine, where he also serves as Clinical Chief of Infectious Diseases and Vice Chair for Education and Academic Affairs in the Department of Internal Medicine. His research focuses on infections among older adults, with particular expertise in endocarditis, meningitis, and antimicrobial stewardship in geriatric populations. Dr. Quagliarello has been an NIH R01-funded principal investigator studying infections in older adults and received an NIH K07 Academic Leadership Award to mentor postdoctoral trainees and junior faculty. His publication record demonstrates consistent focus on antimicrobial use in elderly patients, particularly those with advanced cancer, nursing home residents, and end-of-life care scenarios. His research has significantly contributed to understanding appropriate antimicrobial therapy in geriatric populations and the management of infections in complex elderly patients. Scientific Awards: Clinical Teacher Award (2011) from Infectious Diseases Society of America Leah Lowenstein Award (2007) from Yale School of Medicine Department of Internal Medicine Teacher of the Year (1998, 1990) Laureate Award (1997) from American College of Physicians (CT Chapter) Bohmfalk Teaching Prize (1997) from Yale School of Medicine Dr. Quagliarello has served as an educational leader at Yale, directing the Internal Medicine Clerkship, the Yale Infectious Diseases Fellowship program, and creating the Department of Medicine Research in Residency Program. His clinical work spans the spectrum of infectious diseases with a special focus on public health impact.

• Infectious Diseases
• Geriatric Infectious Diseases
• Antimicrobial Stewardship
• +7 more

Allison Ross Eckard, MD is Professor in the Departments of Pediatrics and Medicine at the Medical University of South Carolina (MUSC) College of Medicine, serving as Division Chief for Pediatric Infectious Diseases and Director of MUSC's Ryan White Pediatric HIV Clinic and HIV Transition Clinic. She maintains an adjunct faculty position at Emory University and holds board certification in Pediatrics and Pediatric Infectious Diseases. Her primary research focuses on metabolic, cardiovascular, and nutritional complications of chronic HIV and antiretroviral therapy across age groups, with emphasis on inflammation's role in comorbidities like cardiovascular disease and bone disorders. Current investigations include NIH R01-funded research on interventions for weight gain and abdominal fat in HIV, vitamin D supplementation, and statin therapy. She has published nearly 60 peer-reviewed papers on HIV pathogenesis and treatment optimization. Dr. Eckard co-chairs the DHHS panel for Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children and serves on the DHHS panel for Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV . Her clinical work specializes in comprehensive HIV care for children through young adults, with particular focus on adolescent/young adult transition issues and global health initiatives through Lespwa Timoun in Haiti. Recent efforts include developing COVID-19 treatment guidelines for children and school safety protocols. HIV Specialist certification (American Academy of HIV Medicine) Fellow, Infectious Diseases Society of America Fellow, Pediatric Infectious Diseases Society Fellow, HIV Medical Association Member, HIV Medical Association's 'Ending the HIV Epidemic' working group She leads MUSC's HIV education initiatives and serves as inpatient consultant for pediatric infectious diseases, with advanced training in tropical medicine. Her NIH-funded research examines targeted interventions to minimize comorbidity development in HIV, while her clinical leadership spans the Ryan White HIV program, transition clinics, and global health partnerships.

• HIV-related cardiometabolic complications
• Antiretroviral therapy optimization
• Pediatric infectious diseases
• +7 more

Zach Shahn is an Assistant Professor in the Department of Epidemiology and Biostatistics at the CUNY School of Public Health. He holds a PhD in Statistics from Columbia University and a BA in Mathematics from Stanford University. His research focuses on causal inference methods applied to healthcare data, particularly time-varying treatment effects and critical care applications. He has conducted postdoctoral work at Harvard School of Public Health and previously worked at IBM Research in Healthcare and Life Sciences. Education: PhD in Statistics and Probability, Columbia University BA in Mathematics, Stanford University Research interests include developing causal inference frameworks for evaluating treatment efficacy in dynamic healthcare settings, with a focus on critical care outcomes and methodological innovations. Recent work explores applications of causal diagrams, instrumental variables, and machine learning in healthcare decision-making. His studies often involve large-scale healthcare datasets to assess interventions' real-world impacts. Key trends in his articles include advancements in causal effect estimation under complex treatment regimes, bias analysis in observational studies, and methodological contributions to difference-in-differences and N-of-1 trial designs. His work bridges statistical theory with practical healthcare challenges, emphasizing reproducibility and policy relevance. No scientific awards are listed, though his contributions to causal inference methodologies are notable in academic circles. He has advised on healthcare data projects and published extensively without explicitly listed grants. His professional network includes collaborations with institutions like Harvard and IBM. He is affiliated with CUNY's public health programs and actively engages in academic discourse via Twitter and LinkedIn. His lab or team details are not explicitly mentioned in available materials.

• Causal Inference
• Healthcare Data Analysis
• Critical Care Applications
• +3 more

Dr. Jennifer L. Aldrich is a Clinical Professor at the Lewis Katz School of Medicine, Temple University. Her clinical and research interests focus on HIV treatment and prevention, LGBTQ health, adult gender-affirming care, correctional medicine, and telemedicine applications in infectious diseases. Education : MD from University of Rochester School of Medicine and Dentistry Training : Fellowship in Infectious Diseases and Residency in Internal Medicine at Hospital of the University of Pennsylvania Certifications : American Board of Internal Medicine (Internal Medicine & Infectious Disease) Memberships : American Academy of HIV Medicine, WPATH, GLMA Her work bridges clinical practice in HIV care, correctional health, and telemedicine, with publications addressing antimicrobial use in critical care and HIV-related wasting syndrome. Scientific awards include membership in Alpha Omega Alpha honor society.

• Treatment of HIV
• Prevention of HIV
• LGBTQ health
• +8 more

Dr. Shufang Sun is an Assistant Professor in the Departments of Behavioral and Social Sciences and Psychiatry and Human Behavior at Brown University’s School of Public Health, and Associate Director of the Mindfulness Center. Her work focuses on understanding how stress, trauma, and systemic inequities contribute to health disparities, particularly among marginalized populations like LGBTQ+ individuals, youth, and communities affected by HIV. She develops mindfulness-based, technology-mediated interventions to promote mental health and reduce stigma, with a global focus including China, the Philippines, and Ukraine. Education: PhD in Counseling Psychology from the University of Wisconsin-Madison (2018). Research interests include mindfulness interventions, mHealth (mobile health), global mental health, HIV prevention, minority stress, and stigma reduction. Her work emphasizes community-engaged research and rigorous evidence synthesis through meta-analyses and systematic reviews. Current projects include interventions for displaced Ukrainians, suicide prevention in rural China, and HIV prevention among transgender women in the Philippines. Her interventions address topics like queer resilience, pandemic mental health, and health equity for vulnerable groups. Awards include the APA’s Barbara Smith Early Career Award and Brown University’s Early Career Research Achievement Award. Grants: Principal investigator on NIH-funded projects totaling over $7.5M, including a $3M R24 grant for mindfulness evidence synthesis and a $621K NIMH grant for school-based suicide prevention in China. Labs/Teams: Director of the Mindfulness for Health Equity Lab, collaborating with global researchers on stigma reduction and digital health innovations.

• Mindfulness-based interventions
• mHealth (mobile health)
• Global mental health
• +7 more

Dr. Mbita Mbao is an Assistant Professor in the School of Social Work at Salem State University, where she teaches courses including SWK 700 (Human Behavior), SWK 704/705 (Social Work Practice), and aging-focused courses like SWK 871. Her teaching philosophy emphasizes experiential learning and valuing student experiences. Dr. Mbao's research focuses on behavioral health, aging populations, workforce development, and immigrant issues. She actively works to expand aging-related curriculum and services through her involvement with the Older Adults Behavioral Health Network and Salem for All Ages initiative. Her education includes a BSW from Bowling Green State University, MSW from Rhode Island College, and PhD from Simmons University. As a Licensed Clinical Independent Social Worker, she maintains a clinical practice providing in-home therapy to older adults. Honors include: 2025 North Star Collective Fellow 2019 AGESW Pre-Dissertation Fellow 2021 GSA MCDTAW Early Career Diversity Fellow

• Behavioral Health
• Aging
• Workforce Development
• +3 more

Sarah Woolf-King is an Assistant Adjunct Professor in the Department of Medicine at the University of California, San Francisco (UCSF), School of Medicine. She is a licensed clinical psychologist (CA PSY28178) whose research bridges psychology and health, with a strong focus on substance use, HIV, and mental health in families affected by congenital heart defects. Her educational background includes a B.S. in Psychology from Arizona State University (2002), an M.S./Ph.D. in Clinical Psychology from Syracuse University (2010), an M.P.H. in Epidemiology from UC Berkeley (2011), a clinical internship in Behavioral Medicine at VA Palo Alto (2010), and a T32 Postdoctoral Fellowship at UCSF’s Center for AIDS Prevention Studies (2013). Dr. Woolf-King’s research centers on two primary areas: (1) the impact of alcohol use on HIV treatment and prevention, particularly among HIV-positive men who have sex with men (MSM) and in East African populations, and (2) the mental health needs of parents of children with critical congenital heart defects (CHD). Her work employs diverse methodologies, including daily data collection, qualitative interviews, randomized trials, and biomarker validation (e.g., PEth). She aims to develop integrated behavioral interventions to improve health outcomes for individuals and families coping with chronic illness. Her recent publications (2023–2025) reflect a consistent focus on alcohol use in the context of HIV, with studies on counseling interventions, digital screening, remote biomarker collection, and behavioral mechanisms. There is also growing attention to mental health in vulnerable populations, including college students and parents of children with genetic or cardiac conditions. Her work is increasingly interdisciplinary, combining psychology, epidemiology, public health, and global health. Scientific Awards: Hellman Fellow, Hellman Fellows Fund (2015–2017) Mentored Research Scientist Development Award (K01), NIH/NIAAA (2013–2018) Loan Repayment Program in Clinical Research, NIH/NIAAA (2011–2016) Ruth L. Kirschstein National Research Service Award (F31), NIH/NIAAA (2008–2010) Mentored Scientist Award in HIV/AIDS, UCSF CFAR (2012–2014) Dr. Woolf-King has served as Principal Investigator on NIH-funded projects, including an R34 grant for a brief ACT intervention for HIV-positive hazardous drinkers and a K01 grant on alcohol and sexual risk behavior. She collaborates extensively with researchers at UCSF and in East Africa, particularly Uganda. While her adjunct title suggests a part-time or non-tenure-track role, she maintains an active research program with significant grant support and a robust publication record. There is no indication of retirement or former staff status.

• Clinical Psychology
• HIV/AIDS
• Substance Use
• +9 more

Dr. Jeremy I. Schwartz is an Associate Professor at Yale School of Medicine (Department of Medicine) and Yale School of Public Health (Department of Chronic Disease Epidemiology). He specializes in non-communicable diseases (NCDs), global health, and digital health interventions. As Firm Chief of Yale Primary Care Residency Program and Director of the Faculty Network Program at the Yale Institute for Global Health, he leads initiatives to improve healthcare delivery in low-resource settings. He co-founded the Uganda Initiative for Integrated Management of Non-Communicable Diseases (UINCD), collaborating with Ugandan institutions to address fragmented NCD care. His research focuses on hypertension, diabetes, and heart failure management in Uganda, leveraging mobile health (mHealth) tools. He also directs the 'Topics in Global Medicine' course at Yale, training future healthcare leaders in global health challenges. Education: MD from University of Rochester School of Medicine & Dentistry (2006), BS from Cornell University (2000). Honors include the Doran J. Stevens Prize (2006), Gold Humanism Honor Society (2006), and Alpha Omega Alpha (2005). Key roles: Medical Director of the Eastern Caribbean Health Outcomes Research Network (ECHORN), Co-Director of UINCD, and affiliated faculty at the Yale Institute for Global Health and Center for Interdisciplinary Research on AIDS. His work emphasizes interdisciplinary collaboration, with a focus on Africa and the Caribbean. Research emphasizes integrated care models, digital health innovations, and policy advocacy for NCDs. Recent projects include adapting mobile health applications for heart failure patients and evaluating cost barriers to essential medicines in Uganda.

• Non-Communicable Diseases
• Global Health
• Health Services Research
• +3 more

Dr. Lauren Cirrincione is an Associate Professor in the Department of Pharmacy at the University of Washington School of Pharmacy in Seattle, Washington. Her academic appointment is within the Department of Pharmacy, which is part of the School of Pharmacy at the University of Washington. Dr. Cirrincione earned her Doctor of Pharmacy (PharmD) degree from the University of Pittsburgh School of Pharmacy and a Master of Public Health (MPH) in epidemiology from the University of Nebraska Medical Center. She completed a clinical pharmacology fellowship in HIV at the University of Nebraska Medical Center. Dr. Cirrincione's research program addresses mechanisms of hormone-mediated drug interactions, with a primary focus on clinical, translational pharmacology in transgender medicine. Her expertise spans Infectious Diseases, Mechanisms of Drug Interactions, Pharmacokinetics-Pharmacodynamics, Transgender and Gender Diverse Research, and Translational Research. Her work examines how gender-affirming hormone therapy interacts with other medications, particularly antiretrovirals, and investigates the clinical implications of these interactions for transgender patients. She has made significant contributions to understanding estradiol concentrations in gender-affirming therapy, kidney function assessment in gender-diverse populations, and the inclusion of transgender individuals in clinical trials. Her publications demonstrate a consistent focus on improving pharmacological care for transgender and gender-diverse individuals, with recent work examining adolescent transgender medicine, psychotropic medication interactions, and self-injection experiences among transgender people on hormone therapy. Her research bridges clinical pharmacology with gender-affirming care, addressing critical gaps in evidence-based practice for this population. Dr. Cirrincione teaches PHRMCY 535: Pharmacotherapeutics V at the University of Washington School of Pharmacy. Her scientific contributions have advanced the field of transgender pharmacology, with particular emphasis on clinical applications and evidence-based approaches to medication management for transgender patients.

• Infectious Diseases
• Mechanisms of Drug Interactions
• Pharmacokinetics-Pharmacodynamics
• +5 more

William John Moss is a Professor in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, where he also holds joint appointments in International Health and Molecular Microbiology and Immunology. He serves as Executive Director of the International Vaccine Access Center (IVAC) and Deputy Director at the Johns Hopkins Malaria Research Institute. His work spans multiple centers including the Center for Global Health, Center for Humanitarian Health, and Johns Hopkins Vaccine Initiative. Dr. Moss earned his MD from Columbia University in 1984 and his MPH in 1995. As a pediatrician with subspecialty training in infectious diseases, he has conducted extensive field research across multiple countries including Ethiopia, Kenya, South Africa, Zambia, Zimbabwe and India. His research focuses on the epidemiology and control of childhood infections in resource-poor settings, with particular emphasis on measles-HIV interactions, malaria transmission in southern Africa, serosurveillance for immunization programs, and care of HIV-infected children in rural Zambia. His recent work (2024-2025) demonstrates continued focus on measles epidemiology, malaria transmission dynamics, and vaccine implementation research, with numerous publications examining immunity gaps, human mobility patterns, and malaria vector biology in African settings. Scientific Awards: Wyeth-Lederle Vaccines and Pediatrics Young Investigator Award in Vaccine Development (1999-2001) Gustave J. Martin Innovative Research Fund Fellow (2001) Advising, Mentoring and Teaching Recognition Award (2007-2008) Dr. Moss leads multiple research projects including studies on HIV-infected children's immune reconstitution, malaria transmission dynamics in southern Zambia, and strengthening immunization systems through serosurveillance. His work bridges clinical medicine, epidemiology, and public health policy to address critical challenges in global infectious disease control.

• Infectious diseases
• Vaccine-preventable diseases
• Infectious disease epidemiology
• +7 more

Pamela Y. Collins is a Bloomberg Centennial Professor and Chair of the Department of Mental Health at the Johns Hopkins Bloomberg School of Public Health. She holds an affiliate professorship at the University of Washington's Department of Psychiatry and Behavioral Sciences. Her work bridges global mental health, HIV care, and stigma reduction. She leads initiatives in low-resource settings, including integrating mental health into HIV programs and developing scalable interventions like the WHO-UNICEF EQUIP initiative. Her research focuses on marginalized populations, including adolescents in urban environments and communities affected by conflict. Education: MD from Cornell University Medical College (1991), MPH from Columbia University (1997), BA from Purdue University (1986). She has held leadership roles at the National Institute of Mental Health (NIMH) and global health organizations like I-TECH. She chairs the American Psychiatric Association’s Council on International Psychiatry and co-chairs the Connecting Climate Minds initiative. Research Interests: Global mental health systems, HIV/mental health integration, stigma reduction, adolescent mental health in urban contexts, and culturally adapted interventions. She pioneered studies on mHealth in Ghana’s prayer camps and co-led the MindKind study on youth data governance. Awards: Over 20 honors including the NIH Merit Award, NIMH Director’s Awards, and the Jeanne Spurlock Minority Fellowship. Her work emphasizes equity and capacity-building in global health. Grants/Advising: Principal investigator on NIH-funded projects like the Kenya adolescent HIV-mental health trial and co-investigator on Ghana’s mHealth/nurse intervention. She advises on climate change and mental health linkages through her role with the Lancet Commission on Adolescent Health. Labs/Teams: Leads the Johns Hopkins Mental Health Department’s global initiatives, collaborating with WHO, UNICEF, and institutions in Kenya, Ghana, and India. Her teams include interdisciplinary experts in implementation science and digital health.

• Global Mental Health
• HIV Care
• HIV and Mental Health Integration
• +3 more

Dr. Margaret Elizabeth Kruk is a Professor of Health Systems at the Harvard T.H. Chan School of Public Health, part of Harvard University. She previously held roles as Associate Professor at Columbia University and Assistant Professor at the University of Michigan. Her research focuses on improving health system quality in low-income countries, using implementation science and econometric methods to evaluate large-scale reforms. She chairs the Lancet Global Health Commission on High Quality Health Systems in the SDG Era and directs the QuEST Network, a multi-country initiative to enhance health systems globally. Education: MD from McMaster University, MPH from Harvard University. Affiliations: Director of QuEST Centers and Network, former roles at UNDP and McKinsey & Company. Her research interests span healthcare quality measurement, maternal and newborn health, and policy solutions for systemic deficits. Key projects include the People’s Voice Survey on health system performance and mobile phone eCohorts for tracking care quality in LMICs. Publications highlight maternal health outcomes, vaccination decision-making, and health system confidence across countries. Grants include NIH funding for maternal-newborn health integration with HIV programs in Tanzania. Twitter: @mkruk

• Health Systems Improvement
• Global Health
• Healthcare Quality Assessment
• +3 more

Nancy Kass is a Professor in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health, where she also holds the Phoebe R. Berman Professorship in Bioethics and Public Health. She serves as Vice Provost for Graduate and Professional Education at Johns Hopkins University and is the Interim Chair of the Department of Health Policy and Management. Additionally, she is Deputy Director for Public Health at the Johns Hopkins Berman Institute of Bioethics and co-directs the Johns Hopkins Fogarty African Bioethics Training Program. ScD, Johns Hopkins University, 1989 BA, Stanford University Postdoctoral Fellowship, Kennedy Institute of Ethics, Georgetown University Dr. Kass’s research focuses on the ethical dimensions of public health policy and research, with particular expertise in bioethics, research ethics, public health ethics, informed consent, learning health systems, and global health ethics . Her work addresses ethical challenges in HIV/AIDS, obesity prevention, genetics, and international research. She has developed influential frameworks for ethical oversight in public health and clinical research. Her recent publications (2024–2025) reflect a strong focus on modernizing clinical research ethics, including optimizing informed consent, integrating clinical trials with medical practice, and enhancing data infrastructure. These works emphasize ethical governance, patient-centered decision-making, and the alignment of research with real-world healthcare delivery. Her scholarship spans high-impact journals such as JAMA and Implementation Science , demonstrating sustained scholarly leadership. GBFFR Annual Award, Global Forum on Bioethics in Research, 2016 Member, National Academy of Medicine (formerly Institute of Medicine), 2008 Fellow, Hastings Center, 2007 Delta Omega Honorary Society in Public Health, 1996 AMTRA (Advising, Mentoring, and Teaching Award), Johns Hopkins, 1996 Dr. Kass has played a pivotal role in education and mentorship, having directed the PhD program in Bioethics and Health Policy for 15 years. She currently leads the Fogarty-funded African Bioethics Training Program, advancing global bioethics capacity. She has served on numerous national and international advisory bodies, including the National Cancer Institute’s central IRB, the National Academy of Medicine, and the WHO Ethics Review Committee. Her leadership extends to chairing the national Precision Medicine Initiative central IRB. She is actively involved in research projects such as the CDC Informed Consent Project, Bioethics of Quality Improvement, and Demonstrating Respect and Acceptable Consent Strategies in patient-centered outcomes research. These initiatives underscore her commitment to ethical innovation in public health and clinical practice.

• Bioethics
• Research Ethics
• Public Health Ethics
• +12 more

Dr. Ronald P. Strauss serves as the Adams Distinguished Professor at the University of North Carolina at Chapel Hill in the Adams School of Dentistry, with additional appointments as Professor of Social Medicine in the School of Medicine and Clinical Professor of Epidemiology in the Gillings School of Global Public Health. He concurrently holds the position of Chief Global Officer for the Adams School of Dentistry and is an active member of the UNC Craniofacial Center Team. His academic credentials include: BA in Biology from Queens College New York DMD from the University of Pennsylvania PhD in Sociology from the University of Pennsylvania Dr. Strauss's research examines the social dimensions of chronic health conditions, with specialized focus on craniofacial differences and HIV/AIDS. His interdisciplinary approach integrates clinical practice, sociological theory, ethical frameworks, and health policy analysis to address stigma, healthcare access barriers, prenatal diagnosis implications, and community engagement strategies. Methodologically, he employs qualitative ethnography and survey research to investigate psychosocial impacts. His scholarly output demonstrates consistent thematic focus across decades, with recent publications revealing intensified examination of structural determinants of health, intersectional disparities in craniofacial care, and innovative community-based HIV/AIDS interventions. Key patterns include transdisciplinary collaboration, emphasis on patient-centered outcomes, and critical analysis of systemic inequities in healthcare delivery. Dr. Strauss directs the campus-wide HIV/AIDS Course annually since 1987 and teaches Social and Health Systems to medical students. As Faculty Director of the CFAR Office of Community Engagement and lead of the Thorp Faculty Engaged Scholars Program, he mentors faculty in community-engaged scholarship while maintaining active clinical and research supervision. He maintains leadership within the UNC Craniofacial Center Team and has conducted international fieldwork across five countries, reflecting his commitment to global health equity through partnerships in Brazil, Israel, Thailand, Moldova, and China.

• Social Medicine
• Craniofacial Research
• HIV/AIDS
• +4 more

Dr. Sara J Becker is a licensed clinical psychologist and implementation scientist at Northwestern University's Feinberg School of Medicine. She serves as the Inaugural Director of the Center for Dissemination and Implementation Science within the Institute for Public Health and Medicine (IPHAM) and holds the Alice Hamilton Professor of Psychiatry title. Her work bridges research and practice, focusing on equitable adoption of evidence-based treatments in community and clinical settings. Education: BA from Dartmouth College (2000), PhD in Clinical Psychology from Duke University (2009), internship at McLean Hospital/Harvard Medical School (2009), and postdoctoral fellowship at Brown University (2011). Dr. Becker’s research spans patient-focused dissemination strategies (e.g., technology-assisted interventions) and provider-focused implementation approaches (e.g., workforce development). Her recent publications highlight innovations in youth substance use treatment, cancer care, HIV prevention, and school-based mental health interventions, emphasizing equitable healthcare access. She has received prestigious awards, including the NIDA MERIT Award (2021) and the Society for Implementation Research Collaboration’s Best Research Symposium Award (2022). Dr. Becker co-leads two NIH-funded centers advancing implementation science and mentors extensively in the field. Scientific Advisory Roles: Substance Abuse and Mental Health Services Administration (2023-2024) NIDA Merit Award Advisory Board (2022-2023) Dr. Becker actively contributes as an editorial board member for Contemporary Clinical Trials and Journal of Substance Use & Addiction Treatment . She also serves on national conference planning committees and NIH review panels.

• Implementation Science
• Public Health
• Substance Use Disorders
• +3 more